What happens for patients and clinics after a stem cell facelift gone wrong? What about other cell injection problems? Cell therapies raise new challenges and risks. You can stop taking a pill or an injection treatment. However, you can’t stop or retract stem cell treatments if there’s a bad side effect. Unlike other kinds of […]
Clinics can’t retract problems like stem cell facelift gone wrong Read More »
Last week I posted my list of 2017 predictions for the stem cell field. Today a couple of days into 2017 I’m more focused on hope than realism. What would I wish for in the stem cell and regenerative medicine arena in the coming year? More stem cell clinical trial data posted and published. There are
Stem cell wish list for 2017 Read More »
Each year I make a list of predictions for the stem cell and regenerative medicine field for the coming new year. Later in this post I list my top 20 stem cell predictions for 2017. In looking at my past predictions I realized this will now be my 7th year doing stem cell/regenerative medicine yearly predictions.
Stem Cell Predictions for 2017 Read More »
Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions,
Grading my stem cell predictions for 2016: how’d I do? Read More »
Some amniotic stem cell clinics seem to be trying to have their cake and eat it too. Generally the amniotic stem cell clinics market their products as “stem cells” and the implication is that living stem cells are used to effectively treat many medical conditions. I have not seen it mentioned that what some of
Wanted both dead & alive: amniotic stem cell clinics sell zombie cells? Read More »
What are the hottest stem cell trends in the field today? Depends who you ask, right? One impartial way to look at stem cell trends is through the lens of publication citations and the focuses of top stem cell papers. In that perhaps somewhat skewed, but interesting approach, the words used in the titles of the
Text mining hottest 50 papers reveals hottest 2016 stem cell trends Read More »
Dear FDA, The stem cell clinic clock is ticking on you. Before the Trump administration rolls in to possibly tie your hands on many important areas of oversight including stem cell clinics, you should take bold action now. Your CBER branch has been preternaturally quiet on taking actual regulatory actions on stem cell clinics for
Open letter to FDA: take action now on stem cell clinics before Trump Read More »
The voting on the 20 nominees for Stem Cell Person of the Year finished at midnight last night. After more than 1,000 votes, we have the top 10 finalists. These ten are some of the most remarkable people in the world of stem cells today. They have all had great impact, but in very diverse
10 finalists for Stem Cell Person of the Year 2016 Read More »
Recently I had the opportunity to talk with the leadership of Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth. How
Asterias interview: stem cell spinal cord injury trials advance Read More »
Some stem cell news headlines from the past week for you folks. Neuroscience: New nerves for old. Fixing stuff like strokes and paralysis. Cambridge’s Gurdon Institute and Stem Cell Institute receive five-year funding boost. Money flow to stem cells FDA “talks” stem cells in NEJM, “Clarifying Stem-Cell Therapy’s Benefits and Risks”, published on same day that 21st Century
Top stem cell & regenerative medicine headlines of the week Read More »